The stock ticker symbol for Cargo Therapeutics, Inc. was CRGX, under which its common shares were publicly traded on the Nasdaq Global Select Market. Following a corporate acquisition agreement and successful tender offer by Concentra Biosciences, the company completed its merger transaction, became a wholly owned subsidiary, and initiated procedures to delist its common stock from the exchange and deregister its securities from public reporting requirements.